Skip to content

CorMedix CRMD Issuances of common stock from employee benefit plans receivable

Issuances of common stock from employee benefit plans receivable at other companies

BillionToOne, Inc.
 logo
BillionToOne, Inc. BLLN
$104.85M
Silvaco Group, Inc. logo
Silvaco Group, Inc.SVCO
$0-100%
Ondas, Inc.
 logo
Ondas, Inc. ONDS
$46.37K+101%
Diamondrock Hospitality Company
 logo
Diamondrock Hospitality Company DRH
$4.11M
Acadia Realty Trust logo
Acadia Realty TrustAKR
$300K-82.5%
CorMedix logo
CorMedixCRMD
$12.32M

Other financials

Income statement

See full
Revenue$127.4M+226%
Gross profit$115.4M+207%
Operating income$63.7M+216%
Net income$38.6M+87.0%
EPS (diluted)$0.43+43.3%

Balance sheet

See full
Cash & equivalents$179.1M+170%
Total debt$4.3M+729%
Total equity$437.0M+280%
Total assets$815.6M+445%

Cash flow

See full
Operating cash flow$42.4M+115%
CapEx$729.0K+7,190%
Free cash flow$41.7M+111%

Valuation

See full
Market cap$605.65M-34.4%
P/E3.4×
P/S1.5×-9.6×

Profitability

See full
Gross margin91.9%-3.5pp
Operating margin48.4%
Net margin45.2%
FCF margin48.7%+38.8pp

Returns & leverage

See full
Return on equity65.6%
Debt / equity0.0×
Current ratio-1.2×

Where this comes from

Reported directly by CorMedix in its filing.

Tagged under the XBRL concept us-gaap:ConversionOfStockAmountIssued1.

The official record: CorMedix’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's issuances of common stock from employee benefit plans receivable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CorMedix's issuances of common stock from employee benefit plans receivable?
CorMedix (CRMD) reported issuances of common stock from employee benefit plans receivable of $12.32M in Q4 2025.
What does issuances of common stock from employee benefit plans receivable mean?
Measures the value of common stock issued in exchange for the conversion of debt or other financial instruments. This metric highlights the non-cash conversion of liabilities into equity, which reduces debt obligations while increasing the number of shares outstanding. It is a key indicator of balance sheet restructuring and potential shareholder dilution.